Traditional drug delivery methods in cardiovascular disease management encounter significant clinical challenges.Cell-derived nanoparticles, known as extracellular vesicles, emerge as a potentially innovative and effective vehicles for curative cardiac therapies.
No takes yet. Share an insight, caveat, or question.
Ilahibaks et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: